PTPRJ and neoplasm: Among various cell types, vascular ECs notably express PTPRJ, which was initially identified as a tumor suppressor gene due to its involvement in negatively regulating several protein tyrosine kinases, including PDGFR, EGFR, VEGFR-2, and HGFR, thereby controlling angiogenesis, cell proliferation, and migration.